Treatment Options for Orthostatic Hypotension
The first-line approach to orthostatic hypotension should include non-pharmacological interventions, with midodrine (5-20mg three times daily) as the primary pharmacological treatment for symptomatic patients whose lives are considerably impaired despite standard clinical care. 1, 2
Non-Pharmacological Interventions
Immediate Measures
- Increased salt intake: 6-10g daily (1-2 teaspoons) unless contraindicated 1
- Acute water ingestion: 500ml, 30 minutes before meals or anticipated orthostatic stress 1
- Physical counter-pressure maneuvers: Leg crossing, squatting, and muscle tensing 1
- Compression garments: Thigh-high compression stockings and abdominal binders providing at least 30-40 mmHg of pressure 1
Lifestyle Modifications
- Exercise: Regular exercise of leg and abdominal muscles, especially swimming 1
- Dietary modifications for postprandial hypotension:
- Small, frequent meals (4-6 per day)
- Reduced carbohydrate content
- Increased dietary fiber and protein
- Avoiding alcoholic beverages 1
Pharmacological Interventions
First-Line Medications
Midodrine (5-20mg three times daily):
Fludrocortisone (0.1-0.3mg daily):
- Increases sodium retention and volume expansion
- Monitor for electrolyte imbalances, particularly potassium 1
Second-Line Medications
Droxidopa (100-600mg TID):
- Strongly recommended for neurogenic orthostatic hypotension 1
Pyridostigmine (30mg 2-3 times daily):
- Consider for patients refractory to other treatments 1
Octreotide:
- Particularly beneficial for postprandial hypotension 1
Treatment Algorithm
Start with non-pharmacological measures:
- Increased salt and water intake
- Compression garments
- Physical counter-maneuvers
- Dietary modifications
If symptoms persist, add pharmacological therapy:
- First-line: Midodrine (starting at 5mg TID, titrate up to 20mg TID as needed)
- Alternative first-line: Fludrocortisone (0.1mg daily, titrate up to 0.3mg as needed)
For refractory cases:
- Add droxidopa (100mg TID, titrate up to 600mg TID)
- Consider pyridostigmine or octreotide for specific cases
Special Considerations
Medication Timing
- Administer midodrine with the last dose no later than 6 PM or 3-4 hours before bedtime 1, 2
- Time medications to cover periods of anticipated orthostatic stress
Monitoring
- Evaluate treatment efficacy based on symptom improvement rather than absolute BP values 1
- Monitor for supine hypertension (BP>180/110 mmHg) 1
- Check orthostatic BP twice daily 1
- Regular electrolyte monitoring, particularly for patients on fludrocortisone 1
Cautions
- Supine hypertension: All pharmacological treatments can cause or worsen this condition 1, 2
- Drug interactions: Use caution when combining midodrine with:
- Cardiac glycosides (risk of bradycardia)
- Other vasoconstrictors (phenylephrine, ephedrine)
- MAO inhibitors
- Alpha-adrenergic blockers 2
Special Populations
- Elderly: Higher risk (20% prevalence), require slow titration 1
- Cardiac disease: Monitor closely for supine hypertension 1
- Renal impairment: Use midodrine with caution, starting at 2.5mg 2
- Diabetic patients: Focus on glucose control in addition to OH management 1
- Heart failure: Start beta-blockers and ACE inhibitors/ARBs at very low doses 1
Common Pitfalls to Avoid
- Focusing on BP numbers rather than symptoms 1
- Overlooking non-pharmacological measures 1
- Improper timing of medications (administering vasopressors too close to bedtime) 1
- Failure to discontinue contributing medications (antihypertensives, antipsychotics, diuretics) 1
- Inadequate monitoring for supine hypertension 1, 2